Nick Cliff
Well-Known Member
- Relationship to Diabetes
- Type 2
I have heard back from AscendPlus as follows:
Ascend Plus is a UK-wide clinical trial testing to see if semaglutide may help protect against heart attacks, strokes and circulatory problems in individuals with Type 2 diabetes.
1) In some individuals, weight loss is a side effect they can experience so you should consider this particularly if you are already of low weight and low BMI.
2) Your blood sugar levels should continue to be monitored by your GP and the trial will not monitor these.
3) Taking sitagliptin should not impact your participation in the trial.
I'll now ponder if it is worth starting the trial...I suppose if I get the placebo I should have no side effects, and if I get the drug and it causes weight loss, I can stop...
Ascend Plus is a UK-wide clinical trial testing to see if semaglutide may help protect against heart attacks, strokes and circulatory problems in individuals with Type 2 diabetes.
1) In some individuals, weight loss is a side effect they can experience so you should consider this particularly if you are already of low weight and low BMI.
2) Your blood sugar levels should continue to be monitored by your GP and the trial will not monitor these.
3) Taking sitagliptin should not impact your participation in the trial.
I'll now ponder if it is worth starting the trial...I suppose if I get the placebo I should have no side effects, and if I get the drug and it causes weight loss, I can stop...